Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
J Am Coll Cardiol ; 84(9): 801-811, 2024 Aug 27.
Artigo em Inglês | MEDLINE | ID: mdl-39168566

RESUMO

BACKGROUND: Rivaroxaban 2.5 mg plus aspirin reduced limb and cardiovascular events and increased bleeding in patients with symptomatic peripheral artery disease (PAD) after lower extremity revascularization in the VOYAGER PAD (Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities) study. Fragile patients are at heightened risk for ischemic and bleeding events. OBJECTIVES: The purpose of this study was to investigate the safety and efficacy of rivaroxaban 2.5 mg in fragile patients from VOYAGER PAD. METHODS: Patients were categorized as fragile based on prespecified criteria (age >75 years, weight ≤50 kg, or baseline estimated glomerular filtration rate <50 mL/min/1.73 m2). The primary efficacy outcome was the composite of acute limb ischemia, major amputation of a vascular etiology, myocardial infarction, ischemic stroke, or cardiovascular death. The principal safety outcome was TIMI major bleeding. RESULTS: Of 6,564 randomized patients, a total of 1,674 subjects were categorized as fragile at baseline. In the placebo arm, fragile patients were at higher risk of the primary outcome (HR: 1.34; 95% CI: 1.12-1.61) and TIMI major bleeding (HR: 1.57; 95% CI: 0.83-2.96), compared with nonfragile patients. The effect of rivaroxaban on the primary endpoint was not modified by frailty status (fragile HR: 0.93; 95% CI: 0.75-1.15; nonfragile HR: 0.83; 95% CI: 0.72-0.97; P interaction = 0.37). Rivaroxaban increased TIMI major bleeding in fragile (HR: 1.54; 95% CI: 0.82-2.91) and nonfragile patients (HR: 1.37; 95% CI: 0.84-2.23; P interaction = 0.65). CONCLUSIONS: Patients with PAD after lower extremity revascularization meeting fragile criteria are at higher risk of ischemic complications and bleeding. Rivaroxaban reduces ischemic risk and increases bleeding regardless of frailty status. These data may assist in personalization of antithrombotic therapy in fragile population.


Assuntos
Aspirina , Quimioterapia Combinada , Inibidores do Fator Xa , Extremidade Inferior , Doença Arterial Periférica , Rivaroxabana , Humanos , Rivaroxabana/administração & dosagem , Rivaroxabana/uso terapêutico , Feminino , Masculino , Idoso , Doença Arterial Periférica/cirurgia , Aspirina/administração & dosagem , Aspirina/uso terapêutico , Extremidade Inferior/irrigação sanguínea , Extremidade Inferior/cirurgia , Inibidores do Fator Xa/administração & dosagem , Inibidores do Fator Xa/uso terapêutico , Inibidores da Agregação Plaquetária/administração & dosagem , Inibidores da Agregação Plaquetária/uso terapêutico , Método Duplo-Cego , Idoso de 80 Anos ou mais , Procedimentos Cirúrgicos Vasculares , Pessoa de Meia-Idade
2.
J Vasc Surg ; 75(2): 660-670.e3, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-34597783

RESUMO

OBJECTIVE: Amputation remains a frequent and feared outcome in patients with peripheral artery disease (PAD). Although typically characterized as major or minor on the extent of tissue loss, the etiologies and outcomes after amputation by extent are not well-understood. In addition, emerging data suggest that the drivers and outcomes of amputation in patients with PAD may differ in those with and without diabetes mellitus (DM). METHODS: The EUCLID trial randomized 13,885 patients with symptomatic PAD, including 5345 with concomitant diabetes, to ticagrelor or clopidogrel and followed them for long-term outcomes. Amputations were prospectively reported by trial investigators. Their primary and contributing drivers were adjudicated using safety data, including infection, ischemia, or multifactorial etiologies. Outcomes following major and minor amputations were analyzed, including recurrent amputation, major adverse limb events, adverse cardiovascular events, and mortality. Multivariable logistic regression models were used to identify independent predictors of minor amputations. Analyses were performed overall and stratified by the presence or absence of DM at baseline. RESULTS: Of the patients randomized, 398 (2.9%) underwent at least one lower extremity nontraumatic amputation, for a total of 511 amputations (255 major and 256 minor) over a median of 30 months. A history of minor amputation was the strongest independent predictor for a subsequent minor amputation (odds ratio, 7.29; 95% confidence interval, 5.17-10.30; P < .001) followed by comorbid DM (odds ratio, 4.60; 95% confidence interval, 3.16-6.69; P < .001). Compared with patients who had a major amputation, those with a minor amputation had similar rates of subsequent major amputation (12.2% vs 13.6%), major adverse limb events (15.1% vs 14.9%), and major adverse cardiovascular events (17.6% vs 16.3%). Ischemia alone was the primary driver of amputation (51%), followed by infection alone (27%), and multifactorial etiologies (22%); however, infection was the most frequent driver in those with DM (58%) but not in those without DM (15%). CONCLUSIONS: Outcomes after amputation remain poor regardless of whether they are categorized as major or minor. The pattern of amputation drivers in PAD differs by history of DM, with infection being the dominant etiology in those with DM and ischemia in those without DM. Greater focus is needed on the prognostic importance of minor amputation and of the multifactorial etiologies of amputation in PAD. Nomenclature with anatomical description of amputations and eliminating terms "major" or "minor" would seem appropriate.


Assuntos
Amputação Cirúrgica/efeitos adversos , Diabetes Mellitus/epidemiologia , Extremidade Inferior/irrigação sanguínea , Doença Arterial Periférica/cirurgia , Complicações Pós-Operatórias/epidemiologia , Idoso , Feminino , Seguimentos , Saúde Global , Humanos , Incidência , Masculino , Estudos Prospectivos , Taxa de Sobrevida/tendências
3.
Jt Comm J Qual Patient Saf ; 47(4): 242-249, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33451897

RESUMO

BACKGROUND: Operating room (OR)-to-ICU handoffs require coordinated communication between clinicians with different professional backgrounds. However, individual studies have not simultaneously evaluated handoff training and OR-to-ICU handoff practices among interprofessional clinicians that participate in these team-based handoffs. METHODS: The objective of this study was to characterize communication training, practices, and preferences of interprofessional clinicians who engage in OR-to-ICU handoffs. The researchers conducted a mixed methods cohort study using surveys (quantitative) and semistructured interviews (qualitative). Surveys aimed to quantitatively assess the quality of prior handoff training, preferences for clinical information in handoffs, and participation in various handoff activities. Interviews aimed to elicit more in-depth clinician perspectives on these topics through open-ended discussion. The frontline clinicians who were surveyed and interviewed included surgery and anesthesia residents, registered nurses, and advanced practice providers who worked in two ICUs at an urban academic medical center in the United States. RESULTS: In a survey with a 71.8% response rate (130/181), 45.7% (32/70) of residents, 17.4% (4/23) of certified registered nurse anesthetists (CRNAs), 83.3% (10/12) of ICU nurse practitioners (NPs), and 81.0% (17/21) of ICU RNs indicated that their clinical degree-granting education had not provided adequate preparation for OR-to-ICU handoffs. On-the-job training was deemed not adequate preparation by 35.7% (25/70) of residents, 21.7% (5/23) of CRNAs, 58.3% (7/12) of ICU NPs, and 23.8% (5/21) of ICU RNs. Through 30 semistructured interviews, clinicians from all professions expressed interest in interprofessional communication education and in understanding the perspectives and priorities of care team members in OR-to-ICU handoffs. Clinicians also highlighted the potential value of interprofessional communication training taking place early in a clinical career, during degree-granting education. CONCLUSION: Clinicians exhibit profession-based differences in OR-to-ICU handoff training, practices, and information needs. Education focused on interprofessional communication is a potential approach to facilitate improved OR-to-ICU handoff communication.


Assuntos
Transferência da Responsabilidade pelo Paciente , Estudos de Coortes , Comunicação , Humanos , Unidades de Terapia Intensiva , Salas Cirúrgicas , Estados Unidos
4.
Clin Transl Sci ; 13(6): 1279-1287, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32506659

RESUMO

Graft function is crucial for successful kidney transplantation. Many factors may affect graft function or cause delayed graft function (DGF), which decreases the prognosis for graft survival. This study was designed to evaluate whether the perioperative use of dexmedetomidine (Dex) could improve the incidence of function of graft kidney and complications after kidney transplantation. A total of 780 patients underwent kidney transplantations, 315 received intravenous Dex infusion during surgery, and 465 did not. Data were adjusted with propensity scores and multivariate logistic regression was used. The primary outcomes are major adverse complications, including DGF and acute rejection in the early post-transplantation phase. The secondary outcomes included length of hospital stay (LOS), infection, overall complication, graft functional status, post-transplantation serum creatinine values, and estimated glomerular filtration rate (eGFR). Dex use significantly decreased DGF (19.37% vs. 23.66%; adjusted odds ratio, 0.744; 95% confidence interval, 0.564-0.981; P = 0.036), risk of infection, risk of acute rejection in the early post-transplantation phase, the risk of overall complications, and LOS. However, there were no statistical differences in 90-day graft functional status or 7-day, 30-day, and 90-day eGFR. Perioperative Dex use reduced incidence of DGF, risk of infection, risk of acute rejection, overall complications, and LOS in patients who underwent kidney transplantation.


Assuntos
Agonistas de Receptores Adrenérgicos alfa 2/administração & dosagem , Dexmedetomidina/administração & dosagem , Rejeição de Enxerto/epidemiologia , Transplante de Rim/efeitos adversos , Assistência Perioperatória/métodos , Adulto , Idoso , Aloenxertos/efeitos dos fármacos , Creatinina/sangue , Feminino , Taxa de Filtração Glomerular/efeitos dos fármacos , Rejeição de Enxerto/diagnóstico , Rejeição de Enxerto/etiologia , Rejeição de Enxerto/prevenção & controle , Sobrevivência de Enxerto/efeitos dos fármacos , Humanos , Incidência , Rim/efeitos dos fármacos , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Risco , Resultado do Tratamento , Adulto Jovem
5.
Rev. argent. cir ; 106(2): 1-10, jun. 2014. ilus
Artigo em Espanhol | LILACS | ID: biblio-957807

RESUMO

Antecedentes: es motvo de controversia la enseñanza de la apendicectomía laparoscópica por los residentes de Cirugía General. Objetvos: analizar los resultados y valorar el desempeño de los residentes de cirugía de los primeros años en la realización de la apendicectomía laparoscópica. Lugar de aplicación: insttución asistencial pública con Servicio de Cirugía General y Programa de Residencia acreditados. Diseño: estudio observacional retrospectvo. Población: número consecutvo de 119 apendicectomías laparoscópicas realizadas por residentes de cirugía entre 2008 y 2011 (período de 33 meses). Método: realización supervisada durante la apendicectomía laparoscópica. Resultados: el tempo medio de cirugía fue de 40 minutos para el caso de las apendicits no complicadas (n=107), y de 130 minutos para las complicadas (n=12). La tasa de conversión fue de 7%, y se registraron diez complicaciones. El tempo medio de internación hospitalaria fue de 2 días para los casos no complicados, y de 5 días para los complicados. No se registró mortalidad. Conclusiones: la apendicectomía laparoscópica realizada por los residentes de los primeros años bajo la supervisión de cirujanos de planta parecería ser una técnica segura y fable en el ámbito del hospital público, dentro de un programa de formación y capacitación de los residentes de cirugía.

6.
Metabolism ; 62(4): 595-603, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23174405

RESUMO

OBJECTIVE: The cellular effects of restricting fat versus carbohydrate during a low-calorie diet are unclear. The aim of this study was to examine acute effects of energy and macronutrient restriction on skeletal muscle insulin signalling in obesity. MATERIALS/METHODS: Eighteen obese individuals without diabetes underwent euglycemic-hyperinsulinemic clamp and skeletal muscle biopsy after: (a) 5days of eucaloric diet (30% fat, 50% carbohydrate), and (b) 5days of a 30% calorie-restricted diet, either low fat/high carbohydrate (LF/HC: 20% fat, 60% carbohydrate) or high-fat/low carbohydrate (HF/LC: 50% fat, 30% carbohydrate). RESULTS: Weight, body composition, and insulin sensitivity were similar between groups after eucaloric diet. Weight loss was similar between groups after hypocaloric diet, 1.3±1.3kg (p<0.0001 compared with eucaloric). Whole-body insulin sensitivity was unchanged after calorie restriction and similar between groups. However, ex vivo skeletal muscle insulin signalling differed depending on macronutrient composition of calorie-restricted diet. Skeletal muscle of the LF/HC group had increased insulin-stimulated tyrosine phosphorylation of IRS-1, decreased insulin-stimulated Ser307 phosphorylation of IRS-1, and increased IRS-1-associated phosphatidylinositol (PI)3-kinase activity. Conversely, insulin stimulation of tyrosine phosphorylated IRS-1 was absent and serine 307 phosphorylation of IRS-1 was increased on HF/LC, with blunting of IRS-1-associated PI3-kinase activity. CONCLUSION: Acute caloric restriction with an LF/HC diet alters skeletal muscle insulin signalling in a way that improves insulin sensitivity, while acute caloric restriction with an HF/LC diet induces changes compatible with insulin resistance. In both cases, ex vivo changes in skeletal muscle insulin signalling appear prior to changes in whole body insulin sensitivity.


Assuntos
Restrição Calórica , Dieta , Resistência à Insulina/fisiologia , Insulina/fisiologia , Músculo Esquelético/fisiologia , Obesidade/fisiopatologia , Transdução de Sinais/fisiologia , Adulto , Glicemia/fisiologia , Western Blotting , Carboidratos da Dieta , Gorduras na Dieta , Proteínas Alimentares , Feminino , Técnica Clamp de Glucose , Humanos , Proteínas Substratos do Receptor de Insulina/fisiologia , Masculino , Pessoa de Meia-Idade , Fosfatidilinositol 3-Quinases/fisiologia , Adulto Jovem
7.
Am J Cardiol ; 110(9 Suppl): 58B-68B, 2012 Nov 06.
Artigo em Inglês | MEDLINE | ID: mdl-23062569

RESUMO

Diabetes mellitus (DM) is the fifth-leading cause of death worldwide and contributes to leading causes of death, cancer and cardiovascular disease, including CAD, stroke, peripheral vascular disease, and other vascular disease. While glycemic management remains a cornerstone of DM care, the co-management of hypertension, atherosclerosis, cardiovascular risk reduction, and prevention of long-term consequences associated with DM are now well recognized as essential to improve long-term survival. Clinical trial evidence substantiates the importance of glycemic control, low-density cholesterol-lowering therapy, blood pressure lowering, control of albuminuria, and comprehensive approaches targeting multiple risk factors to reduce cardiovascular risk. This article presents a review of the role of DM in the pathogenesis of atherosclerosis and cardiac dysfunction, recent evidence on the degree of glycemic control and mortality, and available evidence for a multifaceted approach to improve long-term outcomes for patients.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Complicações do Diabetes/terapia , Hiperglicemia/prevenção & controle , Albuminúria/prevenção & controle , Anticolesterolemiantes/uso terapêutico , Anti-Hipertensivos/uso terapêutico , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/mortalidade , Complicações do Diabetes/mortalidade , Complicações do Diabetes/fisiopatologia , Terapia por Exercício , Humanos , Hiperglicemia/etiologia , Fatores de Risco
8.
J Diabetes Sci Technol ; 6(5): 1038-44, 2012 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-23063029

RESUMO

BACKGROUND: With improved longevity, cystic fibrosis (CF)-related diabetes (CFRD) has emerged as the most common nonpulmonary complication of CF. Patients with CFRD are frequently admitted to the hospital with infections and deterioration of pulmonary function, during which time glycemic control might have an impact on pulmonary function, recovery from infection, and survival. METHODS AND RESULTS: In an attempt to share our insight into inpatient management of CFRD, this article summarizes the experience of our inpatient glucose management team with hospital management of 121 adult CFRD patients who were hospitalized on 410 occasions at the University of Colorado Hospital between January 2009 and September 2011. This is a retrospective chart review descriptive study of inpatient management of CFRD in our center. Our cohort includes CFRD patients treated with basal and mealtime insulin through multiple daily injections or continuous subcutaneous insulin infusion (CSII), as well as patients receiving steroids or enteral nutrition, which adds complexity to the management of CFRD during hospitalization. CONCLUSIONS: Multiple hospitalizations and intensive inpatient management of CF are integral elements of treatment. Inpatient therapy for CFRD requires a customized approach that is uniquely different from that of type 1 or type 2 diabetes. Our experience highlights clinical circumstances such as irregular food intake, high dose steroid therapy, and supplemental tube feeding. For many patients, it is possible to continue CSII therapy during hospitalization through a combination of mutual trust between the patient and hospital staff and oversight provided by the glucose management team.


Assuntos
Fibrose Cística/complicações , Diabetes Mellitus Tipo 2/etiologia , Diabetes Mellitus Tipo 2/terapia , Pacientes Internados , Admissão do Paciente , Adulto , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Fibrose Cística/epidemiologia , Fibrose Cística/terapia , Diabetes Mellitus Tipo 2/epidemiologia , Nutrição Enteral/estatística & dados numéricos , Feminino , Humanos , Hipoglicemiantes/administração & dosagem , Pacientes Internados/estatística & dados numéricos , Insulina/administração & dosagem , Sistemas de Infusão de Insulina/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Admissão do Paciente/estatística & dados numéricos , Estudos Retrospectivos , Adulto Jovem
9.
Am J Hypertens ; 19(4): 366-72, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16580571

RESUMO

BACKGROUND: Cardiovascular mortality is increased in individuals with insulin resistance, and increased oxidant stress is strongly implicated in atherogenesis. Early growth response gene-1 (Egr-1) may be an important link between insulin resistance and oxidant stress. In this study we examined the effects of insulin and oxidant stress on Egr-1 expression in vascular smooth muscle cells (VSMC), and identified mechanisms for these effects on Egr-1. METHODS: Rat VSMC were used to obtain time course and dose-response curves for insulin and oxidant stress on Egr-1 protein expression. Intracellular signaling pathway inhibitors and adenoviral vectors with dominant negative effects on specific signaling pathways were used to determine mechanisms for these effects. RESULTS: Insulin and oxidant stress each significantly stimulate Egr-1 protein expression. Insulin and oxidant stress combined have a greater effect on Egr-1 than either alone. Insulin effects are mediated via the ERK1/2 MAP kinase pathway, whereas oxidant stress effects may be mediated via the ERK5 and p38 MAP kinase pathways. CONCLUSIONS: We demonstrated that insulin and oxidant stress stimulate Egr-1 expression in VSMC. Insulin effects are mediated via the ERK1/2 MAP kinase pathway, whereas oxidant stress effects may be mediated via the ERK5 and p38 MAP kinase pathways. As insulin resistance is characterized by compensatory hyperinsulinemia and selective impairment of the PI 3-kinase pathway with intact signaling along the ERK1/2 MAP kinase pathway, this may have implications for accelerated atherosclerosis in insulin resistance.


Assuntos
Proteína 1 de Resposta de Crescimento Precoce/genética , Regulação da Expressão Gênica , Resistência à Insulina/fisiologia , Sistema de Sinalização das MAP Quinases , Músculo Liso Vascular/citologia , Miócitos de Músculo Liso/fisiologia , Estresse Oxidativo/fisiologia , Animais , Aterosclerose/etiologia , Aterosclerose/fisiopatologia , Células Cultivadas , Relação Dose-Resposta a Droga , Insulina/farmacologia , Insulina/fisiologia , Sistema de Sinalização das MAP Quinases/fisiologia , Proteína Quinase 3 Ativada por Mitógeno/fisiologia , Proteína Quinase 7 Ativada por Mitógeno/fisiologia , Ratos , Transdução de Sinais , Fatores de Tempo , Proteínas Quinases p38 Ativadas por Mitógeno/fisiologia
10.
Horm Behav ; 45(2): 144-55, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15019802

RESUMO

Prior studies of the effects of dehydroepiandrosterone (DHEA) on cognition have produced complex and inconsistent results. We hypothesize that these results may arise, in part, because of DHEA's metabolism into estrogens and androgens that produce opposing effects on cognition. Our study administered 50 mg of oral DHEA daily for 4 weeks in a placebo-controlled crossover design to six postmenopausal women. We measured blood levels of androgens (total testosterone, free testosterone, DHEA, DHEAS), estrogens (estradiol, estrone), and cognitive performance on recognition memory, perceptual identification, digit span memory, and visual attentional vigilance under both drug and placebo conditions. Multiple regression models incorporating the factors of age and body mass index (BMI) were used to ascertain the relation between sex steroids and cognitive performance. Our results demonstrated that estrogens produced a positive effect on recognition memory, while androgens produced a negative effect. This pattern reversed in perceptual identification with estrogens producing a negative effect and androgens producing a positive effect. In addition, BMI produced a negative effect on digit span memory, age produced a negative effect on perceptual identification, and androgens produced a negative effect on visual attentional vigilance. These results help, in part, to explain DHEA's complex effects on cognition. The diverse effects of sex steroids across tasks underscore the importance of identifying the specific cognitive mechanisms influenced by sex steroids and emphasizes that one should not expect sex steroids to produce homogeneous effects across cognitive tasks.


Assuntos
Androgênios/sangue , Cognição/fisiologia , Desidroepiandrosterona/sangue , Estrogênios/sangue , Pós-Menopausa/sangue , Idoso , Análise de Variância , Feminino , Humanos , Pessoa de Meia-Idade , Desempenho Psicomotor/fisiologia , Valores de Referência
11.
Surg Clin North Am ; 82(1): 1-20, xix, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11905939

RESUMO

This article deals with injuries to the celiac trunk, superior and inferior mesenteric arterial injuires. Surgical approaches and physiological implications of interruption of the mesenteric arterial circulation are addressed in detail. Surgical techniques for the management of these injuries and the need for second look operations are also examined.


Assuntos
Traumatismos Abdominais/cirurgia , Artérias/lesões , Veias/lesões , Vísceras/irrigação sanguínea , Traumatismos Abdominais/mortalidade , Artérias/cirurgia , Artéria Celíaca/lesões , Artéria Celíaca/cirurgia , Humanos , Artérias Mesentéricas/lesões , Artérias Mesentéricas/cirurgia , Veias Mesentéricas/lesões , Veias Mesentéricas/cirurgia , Taxa de Sobrevida , Veias/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA